SKINFUSION
Live / Registered — Registered — Section 8 accepted (as of 05 Jun 2025)
What this means for you
Registered since 05 Mar 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87721501
- Registration number
- 5693056
- Mark type
- Design + words
- Filed
- 14 Dec 2017
- Published for opposition
- 01 May 2018
- Registered
- 05 Mar 2019
- Attorney of record
- Vivian Ortiz-Ponce
Goods and services
- Class 005 — Pharmaceuticals: Transdermal drug delivery devices, namely, transdermal patches containing hormones and other therapeutics for use in hormone replacement therapy and transdermal patches for use in the treatment of pain, nausea, acne, women's health disorders, infertility, endocrine disorders, gastrointestinal disorders, neurological disorders and urological disorders
Owner
- Agile Therapeutics, Inc., Princeton, NJ, US
- Agile Therapeutics, Inc., Princeton, NJ, US
- Agile Therapeutics, Inc., Princeton, NJ, US
Prior registrations
Prosecution history
- 05 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 05 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2025 — TEAS SECTION 8 RECEIVED
- 01 May 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 05 Mar 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Mar 2019 — REGISTERED-PRINCIPAL REGISTER
- 29 Jan 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jan 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jan 2019 — STATEMENT OF USE PROCESSING COMPLETE